A chronic myeloid leukemia case with a unique variant philadelphia translocation: T(9;22;21)(q34;q11;p12)

Oncology Letters

Volumn 3, Issue 5, 2012, Pages 1027-1029

  Al Achkar, Walid ^a   Wafa, Abdulsamad ^a   Moassass, Faten ^a   Liehr, Thomas ^b  

^a DEPARTMENT OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Syrian Arab Republic)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Chronic myeloid leukemia; Fluorescence in situ hybridization; High resolution array proven multicolor banding; Imatinib mesylate; Variant philadelphia chromosome

Indexed keywords

ALKALINE PHOSPHATASE; IMATINIB; LACTATE DEHYDROGENASE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARRAY PROVEN MULTICOLOR BANDING; ARTICLE; CASE REPORT; CHROMOSOME 21; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; PHILADELPHIA 1 CHROMOSOME; PROCEDURES; SPLENOMEGALY;

EID: 84857966539     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.623     Document Type: Article

References (20)

1. O'Brien S, Thall PF and Siciliiano MJ: Cytogenetics of chronic myelogeneous leukemia. Baillie'res Clin Hematol 10: 259-276, 1997.
2. Shtivelman E, Lifshitz B, Gale RP and Canaani E: Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature 315: 550-554, 1985.
3. Griffen J: The biology of signal transduction inhibition: basic science to novel therapies. Semin Oncol 28: 3-8, 2001.
4. Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C, Niederwieser D, Resta D, Capdeville R, Zoellner U, Talpaz M, et al: International STI571 CML Study Group: Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 346: 645-652, 2002.
5. Cortes JE, Talpaz M, Giles F, O'Brien S, Rios MB, Shan J, Garcia-Manero G, Faderl S, Thomas DA, Wierda W, Ferrajoli A, et al: Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy. Blood 101: 3794-3800, 2003.
6. Al-Achkar W, Wafa A and Nweder MS: A complex translocation t(5;9;22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia. J Exp Clin Cancer Res 26: 411-415, 2007.
7. Shaffer L, Slovak M, Cambell L (eds.): ISCN (2009): An International System for Human Cytogenetic Nomenclature. S. Karger, Basel, 2009.
8. Weise A, Mrasek K, Fickelscher I, Claussen U, Cheung SW, Cai WW, Liehr T and Kosyakova N: Molecular definition of high-resolution multicolor banding probes: first within the human DNA sequence anchored FISH banding probe set. J Histochem Cytochem 56: 487-493, 2008.
9. Liehr T, Heller A, Starke H, Rubtsov N, Trifonov V, Mrasek K, Weise A, Kuechler A and Claussen U: Microdissection based high resolution multicolor banding for all 24 human chromosomes. Int J Mol Med 9: 335-339, 2002.
10. El-Zimaity MM, Kantarjian H, Talpaz M, O'Brien S, Giles F, Garcia-Manero G, Verstovsek S, Thomas D, Ferrajoli A, Hayes K, et al: Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome. Br J Haematol 125: 187-195, 2004.
11. Bartram CR, Anger B, Carbonell F and Kleihauer E: Involvement of chromosome 9 in variant Ph1 translocation. Leuk Res 9: 1133-1137, 1985.
12. Guillaume B, Ameye G, Libouton JM, Dierlamm J, Vaerman JL, Straetmans N, Ferrant A, Verellen-Dumoulin C and Michaux L: Chronic myeloid leukemia with a rare variant Philadelphia translocation: t(9;22;21)(q34;q11;q22). Cancer Genet Cytogenet 116: 166-169, 2000.
13. Mancini M, Nanni M, Cedrone M, De Cuia MR, Rondinelli MB, Malagnino F and Alimena G: Application of fluorescence in situ hybridization in defining a complex t(9;21;22) Ph formation. Haematologica 79: 536-539, 1994.
14. Vallcorba I, García-Sagredo JM, San Román C, Ferro MT, González A, Cabello P and Villegas A: Translocation (9;22;21) in a chronic myeloid leukemia fluorescence in situ hybridization definition. Cancer Genet Cytogenet 104: 72-73, 1998.
15. Zhang J, Meltzer P, Jenkins R, Guan XY and Trent J: Application of chromosome microdissection probes for elucidation of BCR-ABL fusion and variant Philadelphia chromosome translocations in chronic myelogenous leukemia. Blood 81: 3365-3371, 1993.
16. Calabrese G, Stuppia L, Franchi PG, et al: Complex translocations of the Ph chromosome and Ph negative CML arise from similar mechanisms, as evidenced by FISH analysis. Cancer Genet Cytogenet 78: 153-159, 1994.
17. Takeuchi M, Katayama Y, Okamura A, Yamamoto K, Shimoyama M and Matsui T: Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2). Cancer Genet Cytogenet 179: 85-87, 2007.
18. Mitelman F, Johansson B and Mertens F (eds.): Mitelman Database of Chromosome Aberrations in Cancer, 2009. http://cgap.nci.nih.gov/Chromosomes/Mitelman.
19. Johansson B, Fioretos T and Mitelman F. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 107: 76-94, 2002.
20. Jeandidier E, Dastugue N, Mugneret F, Lafage-Pochitaloff M, Mozziconacci MJ, Herens C, Michaux L, Verellen-Dumoulin C, Talmant P, Cornillet-Lefebvre P, Luquet I, Charrin C, Barin C, Collonge-Rame MA, Pérot C, Van den Akker J, Grégoire MJ, Jonveaux P, Baranger L, Eclache-Saudreau V, Pagès MP, Cabrol C, Terré C and Berger R; Groupe Français de Cytogénétique Hématologique (GFCH): Abnormalities of the long arm of chromosome 21 in 107 patients with hematopoietic disorders: a collaborative retrospective study of the Groupe Français de Cytogénétique Hématologique. Cancer Genet Cytogenet 166: 1-11, 2006